RhoA/ROCK inhibition improves the beneficial effects of glucocorticoid treatment in dystrophic muscle: implications for stem cell depletion-Reference-Cited by-同舟云学术

RhoA/ROCK inhibition improves the beneficial effects of glucocorticoid treatment in dystrophic muscle: implications for stem cell depletion

Author:

Mu Xiaodong¹²,Tang Ying³,Takayama Koji⁴,Chen Wanqun¹⁵,Lu Aiping¹²,Wang Bing³,Weiss Kurt³,Huard Johnny¹²

Affiliation:

1. Department of Orthopaedic Surgery, University of Texas Health Science Center at Houston, Houston, TX 77054, USA

2. Center for Regenerative Sports Medicine, Steadman Philippon Research Institute, Vail, CO 81657, USA

3. Department of Orthopaedic Surgery, University of Pittsburgh, Pittsburgh, PA 15219, USA

4. Department of Orthopaedic Surgery, Kobe University Graduate School of Medicine, Kobe 650-0017, Japan

5. Department of Biochemistry and Molecular Biology, Jinan University, Guangdong, China

Funder

National Institutes of Health

Publisher

Oxford University Press (OUP)

Subject

Genetics(clinical),Genetics,Molecular Biology,General Medicine

Link

Reference67 articles.

1. Glucocorticoid corticosteroids for Duchenne muscular dystrophy;Manzur;Cochrane Database Syst Rev,2004

2. [Glucocorticoid therapy in Duchenne muscular dystrophy];Kang;Rinsho Shinkeigaku,1996

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献